LEP and cancer: Both interventions were found to be equally good at a weight and showed improvement in risk markers of CVDs, cancer, and diabetes for example reduction in leptin, leptin to adiponectin ratio, inflammatory markers, fasting insulin, insulin resistance, blood pressure, and lipids (110).